Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems

Detalhes bibliográficos
Autor(a) principal: Tavares Luiz, Marcela
Data de Publicação: 2021
Outros Autores: Santos Rosa Viegas, Juliana, Palma Abriata, Juliana, Viegas, Felipe, Testa Moura de Carvalho Vicentini, Fabiana, Lopes Badra Bentley, Maria Vitória, Chorilli, Marlus [UNESP], Maldonado Marchetti, Juliana, Tapia-Blácido, Delia Rita
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.ejpb.2021.05.011
http://hdl.handle.net/11449/233175
Resumo: Nanotechnology has been widely applied to develop drug delivery systems to improve therapeutic performance. The effectiveness of these systems is intrinsically related to their physicochemical properties, so their biological responses are highly susceptible to factors such as the type and quantity of each material that is employed in their synthesis and to the method that is used to produce them. In this context, quality-oriented manufacturing of nanoparticles has been an important strategy to understand and to optimize the factors involved in their production. For this purpose, Design of Experiment (DoE) tools have been applied to obtain enough knowledge about the process and hence achieve high-quality products. This review aims to set up the bases to implement DoE as a strategy to improve the manufacture of nanocarriers and to discuss the main factors involved in the production of the most common nanocarriers employed in the pharmaceutical field.
id UNSP_35ce44cb2ed72bb2f3cdf65241574f3e
oai_identifier_str oai:repositorio.unesp.br:11449/233175
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systemsBox-Behnken DesignCentral Composite DesignFractional Factorial DesignFull Factorial DesignNanomedicineNanotechnologyPlackett-Burman DesignQuality by DesignResponse Surface MethodologyNanotechnology has been widely applied to develop drug delivery systems to improve therapeutic performance. The effectiveness of these systems is intrinsically related to their physicochemical properties, so their biological responses are highly susceptible to factors such as the type and quantity of each material that is employed in their synthesis and to the method that is used to produce them. In this context, quality-oriented manufacturing of nanoparticles has been an important strategy to understand and to optimize the factors involved in their production. For this purpose, Design of Experiment (DoE) tools have been applied to obtain enough knowledge about the process and hence achieve high-quality products. This review aims to set up the bases to implement DoE as a strategy to improve the manufacture of nanocarriers and to discuss the main factors involved in the production of the most common nanocarriers employed in the pharmaceutical field.School of Pharmaceutical Sciences of Ribeirao Preto University of Sao PauloDepartment of Computer Science Federal University of Minas Gerais, Belo HorizonteSchool of Pharmaceutical Sciences Sao Paulo State UniversityDepartment of Chemistry Faculty of Philosophy Sciences and Letters of Ribeirao Preto University of São PauloSchool of Pharmaceutical Sciences Sao Paulo State UniversityUniversidade de São Paulo (USP)Universidade Federal de Minas Gerais (UFMG)Universidade Estadual Paulista (UNESP)Tavares Luiz, MarcelaSantos Rosa Viegas, JulianaPalma Abriata, JulianaViegas, FelipeTesta Moura de Carvalho Vicentini, FabianaLopes Badra Bentley, Maria VitóriaChorilli, Marlus [UNESP]Maldonado Marchetti, JulianaTapia-Blácido, Delia Rita2022-05-01T05:29:28Z2022-05-01T05:29:28Z2021-08-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article127-148http://dx.doi.org/10.1016/j.ejpb.2021.05.011European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 127-148.1873-34410939-6411http://hdl.handle.net/11449/23317510.1016/j.ejpb.2021.05.0112-s2.0-85108303638Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEuropean Journal of Pharmaceutics and Biopharmaceuticsinfo:eu-repo/semantics/openAccess2024-06-24T13:45:19Zoai:repositorio.unesp.br:11449/233175Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T15:41:43.461040Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems
title Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems
spellingShingle Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems
Tavares Luiz, Marcela
Box-Behnken Design
Central Composite Design
Fractional Factorial Design
Full Factorial Design
Nanomedicine
Nanotechnology
Plackett-Burman Design
Quality by Design
Response Surface Methodology
title_short Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems
title_full Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems
title_fullStr Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems
title_full_unstemmed Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems
title_sort Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems
author Tavares Luiz, Marcela
author_facet Tavares Luiz, Marcela
Santos Rosa Viegas, Juliana
Palma Abriata, Juliana
Viegas, Felipe
Testa Moura de Carvalho Vicentini, Fabiana
Lopes Badra Bentley, Maria Vitória
Chorilli, Marlus [UNESP]
Maldonado Marchetti, Juliana
Tapia-Blácido, Delia Rita
author_role author
author2 Santos Rosa Viegas, Juliana
Palma Abriata, Juliana
Viegas, Felipe
Testa Moura de Carvalho Vicentini, Fabiana
Lopes Badra Bentley, Maria Vitória
Chorilli, Marlus [UNESP]
Maldonado Marchetti, Juliana
Tapia-Blácido, Delia Rita
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Universidade Federal de Minas Gerais (UFMG)
Universidade Estadual Paulista (UNESP)
dc.contributor.author.fl_str_mv Tavares Luiz, Marcela
Santos Rosa Viegas, Juliana
Palma Abriata, Juliana
Viegas, Felipe
Testa Moura de Carvalho Vicentini, Fabiana
Lopes Badra Bentley, Maria Vitória
Chorilli, Marlus [UNESP]
Maldonado Marchetti, Juliana
Tapia-Blácido, Delia Rita
dc.subject.por.fl_str_mv Box-Behnken Design
Central Composite Design
Fractional Factorial Design
Full Factorial Design
Nanomedicine
Nanotechnology
Plackett-Burman Design
Quality by Design
Response Surface Methodology
topic Box-Behnken Design
Central Composite Design
Fractional Factorial Design
Full Factorial Design
Nanomedicine
Nanotechnology
Plackett-Burman Design
Quality by Design
Response Surface Methodology
description Nanotechnology has been widely applied to develop drug delivery systems to improve therapeutic performance. The effectiveness of these systems is intrinsically related to their physicochemical properties, so their biological responses are highly susceptible to factors such as the type and quantity of each material that is employed in their synthesis and to the method that is used to produce them. In this context, quality-oriented manufacturing of nanoparticles has been an important strategy to understand and to optimize the factors involved in their production. For this purpose, Design of Experiment (DoE) tools have been applied to obtain enough knowledge about the process and hence achieve high-quality products. This review aims to set up the bases to implement DoE as a strategy to improve the manufacture of nanocarriers and to discuss the main factors involved in the production of the most common nanocarriers employed in the pharmaceutical field.
publishDate 2021
dc.date.none.fl_str_mv 2021-08-01
2022-05-01T05:29:28Z
2022-05-01T05:29:28Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.ejpb.2021.05.011
European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 127-148.
1873-3441
0939-6411
http://hdl.handle.net/11449/233175
10.1016/j.ejpb.2021.05.011
2-s2.0-85108303638
url http://dx.doi.org/10.1016/j.ejpb.2021.05.011
http://hdl.handle.net/11449/233175
identifier_str_mv European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 127-148.
1873-3441
0939-6411
10.1016/j.ejpb.2021.05.011
2-s2.0-85108303638
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv European Journal of Pharmaceutics and Biopharmaceutics
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 127-148
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128551101136896